A subgroup analysis further demonstrated that the HCC patients with EGV had significantly poorer OS rates than those without EGV in most of the subgroups except in regards to serum albumin > 4 g/dL and a platelet count ≤ 105/mm3 (Fig. 4A). The gene discussed is ALB; the disease is hepatocellular carcinoma.